Prograf as secondary intervention vs continuation of cyclosporine in patients at risk for chronic renal allograft failure (CRAF) results in improved renal function, decreased CV risk, and no increased risk for diabetes

Publication Type
Journal Article
Year of Publication
2003
Authors
the CRAF Study Group
Date Published
2003
Location
Washington D.C.